{"entity":{"id":"verity-pharma","kind":"company","name":"Verity Pharmaceuticals","aka":[],"tldr":"Verity Pharmaceuticals is a Canadian specialty company that holds the US application for triptorelin (Trelstar) for advanced prostate cancer.","summary":"Verity Pharmaceuticals, based in Mississauga, Ontario, is a Canadian specialty company that holds the US application for triptorelin, sold as Trelstar, for advanced prostate cancer. It markets Trelstar, triptorelin pamoate, in North America and a portfolio of specialty medicines in Canada. OnCo links it to the triptorelin drug record. Whether older injectable hormone therapies keep their place as oral GnRH antagonists spread is the question that bears on its main oncology product. Triptorelin has its own page.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://www.veritypharma.com"}],"tags":[],"related":[],"cancers":["prostate"],"sections":[],"technologies":[],"targets":["gnrhr"],"drugs":["triptorelin"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":["nct05037279"],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"hq":"Mississauga, Ontario","country":"CA","companyType":"pharma","website":"https://www.veritypharma.com","investors":[],"funding":[]},"route":"/companies/verity-pharma/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"target":[{"id":"gnrhr","kind":"target","name":"GnRH receptor (GNRHR)","route":"/targets/gnrhr/"}],"drug":[{"id":"triptorelin","kind":"drug","name":"Triptorelin","route":"/drugs/triptorelin/"}],"trial":[{"id":"nct05037279","kind":"trial","name":"Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC)","route":"/trials/nct05037279/"}]}}